Open wounds that simply won't heal are a pain for those affected. They cause pain, restrict freedom of movement and, in the worst case, can even lead to amputation. The problem behind this is often excessive inflammation, which blocks the healing process. There is currently no effective treatment for this cause. But that could soon change.
The Leibniz Institute of Polymer Research Dresden (IPF) launched its tenth spin-off in June 2025. ResCure GmbH wants to bring an innovative wound dressing to the market that specifically combats chronic inflammation. The special feature is a special plastic, a polymer that neutralizes inflammatory messengers in the body. A clinical study is currently underway at several clinics focusing on open leg ulcers. The interim results are promising and the study is due to be completed in summer 2026.
European Union supports the transfer
ResCure GmbH recently acquired the patents and trademark rights from the Leibniz Institute of Polymer Research Dresden. This creates the basis for subsequent commercialization. The European Union is supporting the technology transfer with funding from the Sächsische Aufbaubank. The young company is systematically preparing for CE certification, which is mandatory for medical products in Europe. At the same time, it is expanding production in order to be able to deliver quickly after approval.
